Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Antoniou

Showing results (221-230 of 395) with videos related to

Pageof 40
Sort By:
Communications Medicine|April 21, 2026
Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in CanadaNareh Safieh-Garabedian, Antonis C Antoniou, Jennifer Brooks, et al.
JNCI Cancer Spectrum|December 20, 2019
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management ToolKelly-Anne Phillips, Yuyan Liao, Roger L Milne, et al.
Journal of Medical Genetics|October 11, 2017
Inherited mutations in <i>BRCA1</i> and <i>BRCA2</i> in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from MalaysiaWei Xiong Wen, Jamie Allen, Kah Nyin Lai, et al.
British Journal of Cancer|September 11, 2008
An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriersA Osorio, M Pollán, G Pita, et al.
Breast Cancer Research and Treatment|January 4, 2012
The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriersYael Laitman, Karoline B Kuchenbaecker, Johanna Rantala, et al.
Genome Biology|January 9, 2020
Non-coding RNAs underlie genetic predisposition to breast cancerMahdi Moradi Marjaneh, Jonathan Beesley, Tracy A O'Mara, et al.
Breast Cancer Research : BCR|May 21, 2025
Distribution of age at natural menopause, age at menarche, menstrual cycle length, height and BMI in BRCA1 and BRCA2 pathogenic variant carriers and non-carriers: results from EMBRACENasim Mavaddat, Debra Frost, Emily Zhao, et al.
Journal of Medical Genetics|July 5, 2005
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studiesA C Antoniou, P D P Pharoah, S Narod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in SpainRoger L Milne, Ana Osorio, Teresa Ramón Y Cajal, et al.
Journal of the National Cancer Institute|December 29, 2020
Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation CarriersJulika Borde, Corinna Ernst, Barbara Wappenschmidt, et al.
Pageof 40

Showing results (221-230 of 395) with videos related to

Sort By:
Pageof 40
Communications Medicine|April 21, 2026
Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in CanadaNareh Safieh-Garabedian, Antonis C Antoniou, Jennifer Brooks, et al.
JNCI Cancer Spectrum|December 20, 2019
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management ToolKelly-Anne Phillips, Yuyan Liao, Roger L Milne, et al.
Journal of Medical Genetics|October 11, 2017
Inherited mutations in <i>BRCA1</i> and <i>BRCA2</i> in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from MalaysiaWei Xiong Wen, Jamie Allen, Kah Nyin Lai, et al.
British Journal of Cancer|September 11, 2008
An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriersA Osorio, M Pollán, G Pita, et al.
Breast Cancer Research and Treatment|January 4, 2012
The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriersYael Laitman, Karoline B Kuchenbaecker, Johanna Rantala, et al.
Genome Biology|January 9, 2020
Non-coding RNAs underlie genetic predisposition to breast cancerMahdi Moradi Marjaneh, Jonathan Beesley, Tracy A O'Mara, et al.
Breast Cancer Research : BCR|May 21, 2025
Distribution of age at natural menopause, age at menarche, menstrual cycle length, height and BMI in BRCA1 and BRCA2 pathogenic variant carriers and non-carriers: results from EMBRACENasim Mavaddat, Debra Frost, Emily Zhao, et al.
Journal of Medical Genetics|July 5, 2005
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studiesA C Antoniou, P D P Pharoah, S Narod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in SpainRoger L Milne, Ana Osorio, Teresa Ramón Y Cajal, et al.
Journal of the National Cancer Institute|December 29, 2020
Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation CarriersJulika Borde, Corinna Ernst, Barbara Wappenschmidt, et al.
Pageof 40